Skip to main content
TOPICS
Videos
Podcasts
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Parkinson's tremors
Cala Health secures $50M to scale wearable neuromodulation therapy
By
Jessica Hagen
|
04:51 pm |
April 20, 2026
The company's FDA-cleared wearable uses personalized nerve stimulation to treat essential tremor and Parkinson's disease.